By www.reliablebusinessinsights.com
Global Proprotein Convertase Subtilisin & Kexin Type 9 Market Research Report 2024 Story
95
$ 2900
Proprotein Convertase Subtilisin & Kexin Type 9 Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
AFFiRiS AG Betagenon AB Bioleaders Corp BioLingus AG Catabasis Pharmaceuticals Inc Dicerna Pharmaceuticals Inc Eli Lilly and Co Ensemble Therapeutics Corp Kowa Co Ltd Novartis AG Pfizer Inc Regeneron Pharmaceuticals Inc Serometrix LLC Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd The Medicines Company